Cerenome (CNSY) news
Recent news
CerenoMed Inc 2Q cash & cash equivalents $2.37M
CerenoMed Inc reported $2.37 million in cash and cash equivalents as of the second quarter of 2024, reflecting the company’s liquidity position during the period. This figure provides insight into the firm’s short-term financial flexibility and capacity to fund ongoing operations or strategic…
AInvest Wire · Aug 14, 2026Cerenome Inc 2Q loss/share $1.31
Cerenome Inc. reported a second-quarter loss of $1.31 per share, reflecting ongoing financial challenges for the biotechnology firm. The company has not disclosed detailed earnings reports or specific financial figures beyond this loss-per-share metric, leaving investors with limited insight into…
AInvest Wire · Aug 14, 2026Light Horse does not author, endorse or verify the headlines, and their appearance here is not an endorsement of any view they express.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.